Inhibition of tau-tau-association
US8278298B2 · kind B2 · utility
3Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2006 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Jun 4, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A composition and use thereof for the prophylaxis or treatment of Alzheimer's disease, motor neurone disease, Lewy body disease, Pick's disease or progressive supranuclear palsy. The composition includes an agent which modulates or inhibits tau-tau association and which does not inhibit tau-tubulin binding. In the method the agent is administered to an individual in order to achieve the desired therapeutic effect. Preferably the agent which is administered is a phenothiazine compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.